CAS: 130610-93-4 - Niravoline
Formula:C22H25N3O3
InChI:InChI=1S/C22H25N3O3/c1-23(21(26)14-16-7-6-9-18(13-16)25(27)28)22-19-10-3-2-8-17(19)15-20(22)24-11-4-5-12-24/h2-3,6-10,13,20,22H,4-5,11-12,14-15H2,1H3/t20-,22-/m0/s1
InChI key:InChIKey=ZSDAQBWGAOKTSI-UNMCSNQZSA-N
SMILES:O=C(N(C)C1C=2C=CC=CC2CC1N3CCCC3)CC=4C=CC=C(C4)N(=O)=O
- Synonyms:
- Benzeneacetamide, N-[(1S,2S)-2,3-dihydro-2-(1-pyrrolidinyl)-1H-inden-1-yl]-N-methyl-3-nitro-
- Benzeneacetamide, N-[2,3-dihydro-2-(1-pyrrolidinyl)-1H-inden-1-yl]-N-methyl-3-nitro-, (1S-trans)-
- N-Methyl-2-(m-nitrophenyl)-N-((1S,2S)-2-(1-pyrrolidinyl)-1-indanyl)acetamide
- N-[(1S,2S)-2,3-Dihydro-2-(1-pyrrolidinyl)-1H-inden-1-yl]-N-methyl-3-nitrobenzeneacetamide
- N-methyl-2-(3-nitrophenyl)-N-[(2S)-2-(pyrrolidin-1-yl)-2,3-dihydro-1H-inden-1-yl]acetamide
- Niravoline [INN]
- Ru 51599
- Unii-R8T17Q4Lxc
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Niravoline REF: TR-N000005CAS: 130610-93-4 | - - - | 13,287.00 € | Tue 21 Jan 25 | |
Niravoline REF: 3D-FFA61093CAS: 130610-93-4 | Min. 95% | To inquire | Tue 21 Jan 25 | |
Niravoline REF: TM-T71019CAS: 130610-93-4 | - - - | 178.00 €~1,796.00 € | Mon 10 Mar 25 |
Niravoline
Controlled ProductCAS:130610-93-4
Formula:
C22H25N3O3
Color and Shape:
Neat
Molecular weight:
379.452
Ref: TR-N000005
25mg | 13,287.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Niravoline
CAS:130610-93-4
Niravoline is a fatty acid ester that has shown to reduce blood pressure. No other …
Formula:
C22H25N3O3
Purity:
Min. 95%
Molecular weight:
379.5 g/mol
Ref: 3D-FFA61093
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Niravoline
CAS:130610-93-4
Niravoline is a kappa-opioid agonist.
Formula:
C22H25N3O3
Color and Shape:
Liquid
Molecular weight:
379.45
Ref: TM-T71019
1mg | 178.00 € | ||
5mg | 441.00 € | ||
10mg | 631.00 € | ||
25mg | 985.00 € | ||
50mg | 1,359.00 € | ||
100mg | 1,796.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025